Traws Pharma, Inc. — Director's Dealing 2013

Nov 19, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-11-15

Reporting Person: Bienen Henry S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-15	Common Stock	P	1248	$12.18	Acquired	14783	Direct
2013-11-15	Common Stock	P	152	$12.09	Acquired	14935	Direct